Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel M Behar

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|December 11, 2023
Heterogeneity in lung macrophage control of <i>Mycobacterium tuberculosis</i> is determined by T cellsRocky Lai, Travis Williams, Tasfia Rakib, et al.
Journal of Virology|March 11, 2011
Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceNatalie V Akhrameyeva, Pengwei Zhang, Nao Sugiyama, et al.
Infection and Immunity|November 24, 2004
The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H miceArati B Kamath, Jennifer Alt, Hajer Debbabi, et al.
Nature Reviews. Immunology|June 13, 2025
Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine designEmma Lefrançais, Denis Hudrisier, Olivier Neyrolles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activationMarkus Sköld, Xiaowei Xiong, Petr A Illarionov, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infectionIsabel Sada-Ovalle, Markus Sköld, Tian Tian, et al.
Nature Immunology|July 13, 2010
Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosisMaziar Divangahi, Danielle Desjardins, Cláudio Nunes-Alves, et al.
Infection and Immunity|March 12, 2008
Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infectionYing Wu, Joshua S Woodworth, Daniel S Shin, et al.
Cell Reports|August 31, 2025
CD226 identifies effector CD8<sup>+</sup> T cells during tuberculosis and costimulates recognition of Mycobacterium tuberculosis-infected macrophagesTomoyo Shinkawa, Evelyn Chang, Tasfia Rakib, et al.
Trends in Immunology|June 24, 2011
Emerging Tim-3 functions in antimicrobial and tumor immunityKaori Sakuishi, Pushpa Jayaraman, Samuel M Behar, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|December 11, 2023
Heterogeneity in lung macrophage control of <i>Mycobacterium tuberculosis</i> is determined by T cellsRocky Lai, Travis Williams, Tasfia Rakib, et al.
Journal of Virology|March 11, 2011
Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceNatalie V Akhrameyeva, Pengwei Zhang, Nao Sugiyama, et al.
Infection and Immunity|November 24, 2004
The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H miceArati B Kamath, Jennifer Alt, Hajer Debbabi, et al.
Nature Reviews. Immunology|June 13, 2025
Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine designEmma Lefrançais, Denis Hudrisier, Olivier Neyrolles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activationMarkus Sköld, Xiaowei Xiong, Petr A Illarionov, et al.
American Journal of Respiratory and Critical Care Medicine|May 29, 2010
Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infectionIsabel Sada-Ovalle, Markus Sköld, Tian Tian, et al.
Nature Immunology|July 13, 2010
Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosisMaziar Divangahi, Danielle Desjardins, Cláudio Nunes-Alves, et al.
Infection and Immunity|March 12, 2008
Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infectionYing Wu, Joshua S Woodworth, Daniel S Shin, et al.
Cell Reports|August 31, 2025
CD226 identifies effector CD8<sup>+</sup> T cells during tuberculosis and costimulates recognition of Mycobacterium tuberculosis-infected macrophagesTomoyo Shinkawa, Evelyn Chang, Tasfia Rakib, et al.
Trends in Immunology|June 24, 2011
Emerging Tim-3 functions in antimicrobial and tumor immunityKaori Sakuishi, Pushpa Jayaraman, Samuel M Behar, et al.
Pageof 12